"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about LORAZEPAM
• Ask Community about LORAZEPAM
• LORAZEPAM Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

LORAZEPAM Safety Questions, LORAZEPAM Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LORAZEPAM. Our extensive database of LORAZEPAM adverse events and LORAZEPAM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LORAZEPAM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

LORAZEPAM Safety Reports

Total LORAZEPAM reports: 184.
LORAZEPAM FDA safety alerts: 2007 .
Reported deaths: 38    Reported hospitalizations: 102.
Take LORAZEPAM Side Effects Survey or Share Your LORAZEPAM Story. LORAZEPAM Usage.

Showing 1-75 of 184 Next >

Pharmacist from UNITED STATES reported LORAZEPAM problem on June 12, 2007. Female patient was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood osmolarity increased, renal impairment, therapeutic agent toxicity. LORAZEPAM dosage: unknown. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 26 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. LORAZEPAM dosage: unknown. During the same period patient was treated with METHADONE, FLUOXETINE. Patient died on 01/01/2003.

Health Professional from UNITED KINGDOM reported LORAZEPAM problem on June 07, 2007. Male patient, 62 years of age, was diagnosed with depression, panic attack and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: abdominal injury, agitation, anxiety, chest injury, delusional disorder, somatic type, euphoric mood, fear. LORAZEPAM dosage: unknown. During the same period patient was treated with ALPRAZOLAM, TEMAZEPAM, FLUOXETINE. Patient recovered.

LORAZEPAM problem was reported by a Pharmacist from UNITED STATES on Apr 09, 2007. Female patient, 84 years of age, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: dry mouth, dry skin, gait disturbance, herpes zoster, upper limb fracture. LORAZEPAM dosage: 0.05 MG, PRN, ORAL. During the same period patient was treated with XALITIN EYE DROPS. Patient recovered.

Physician from UNITED STATES reported LORAZEPAM problem on June 11, 2007. Male patient, 36 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: aggression, condition aggravated, delusion, hallucination, auditory, mental disorder, pain, psychotic disorder, salivary hypersecretion. LORAZEPAM dosage: 0.5 MG; TID; PO. During the same period patient was treated with CLOZAPINE, HALOPERIDOL, QUETIAPINE, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Health Professional from SPAIN on June 08, 2007. Female patient, 67 years of age, was diagnosed with dyspepsia, dizziness and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: hepatitis, oedema, stevens-johnson syndrome, thrombocytopenia. LORAZEPAM dosage: (1 MG QD ORAL). During the same period patient was treated with NEXIUM, DOGMATIL, PANTECTA. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LORAZEPAM problem on June 19, 2006. Female patient, 57 years of age, was diagnosed with insomnia, depression, chronic obstructive pulmonary disease and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: mental disorder. LORAZEPAM dosage: unknown. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Pharmacist from UNITED STATES on July 10, 2006. Male patient, weighting 121.3 lb, was diagnosed with anxiety, sleep disorder, pain and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: alcoholism, anxiety disorder, cerebrovascular accident, fall, gait disturbance, gastrooesophageal reflux disease, hypertension, intermittent claudication, loss of consciousness. LORAZEPAM dosage: 0.5 MG HS PO. During the same period patient was treated with AMITRIPTYLINE, ATENOLOL, ATROPINE, FIKUC ACUD, LASIX, LISINOPRIL, PRILOSEC. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LORAZEPAM problem on June 27, 2006. Male patient was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: panic attack. LORAZEPAM dosage: 1 MG; PO. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Physician from JAPAN on June 28, 2006. Female patient, weighting 6.61 lb, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: caesarean section, feeding disorder neonatal, hypersomnia, hypokinesia neonatal, neonatal disorder, poor sucking reflex. LORAZEPAM dosage: 1 MG Q DAY TRAN-P. During the same period patient was treated with PAXIL, BENZALIN, LENDORMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORAZEPAM problem on July 10, 2006. Female patient, 29 years of age, weighting 115.0 lb, was diagnosed with insomnia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: accidental overdose, amnesia, anxiety, confusional state, dizziness, gait disturbance, somnolence. LORAZEPAM dosage: 2 MG;PRN;PO. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Physician from UNITED STATES on July 10, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with endocrine pancreatic disorder, pancreatic neoplasm and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, aspartate aminotransferase increased, chills, dehydration, diarrhoea, fatigue, flatulence, hypoaesthesia, hypotension. LORAZEPAM dosage: 1 MG Q2W, ORAL. During the same period patient was treated with OXALIPLATIN, BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN, DEXAMETHASONE, GRANISETRON. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported LORAZEPAM problem on July 11, 2006. Female patient, 44 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: alcohol use, breath odour, disturbance in attention, laboratory test abnormal, somnolence, suicide attempt. LORAZEPAM dosage: unknown. During the same period patient was treated with TEMAZEPAM, ALCOHOL. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from on July 05, 2006. Female patient, 66 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: eye movement disorder, oxygen saturation decreased, serotonin syndrome, trismus. LORAZEPAM dosage: 10 MG ONCE PO. During the same period patient was treated with MIDAZOLAM, TRANYLCYPROMINE SULPHATE, TRIFLUOPERAZINE, FLUOXETINE, PANCURONIUM, REMIFENTANIL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LORAZEPAM problem on Aug 01, 2006. Female patient, 55 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: confusional state, oxygen saturation decreased, respiratory depression, sedation. LORAZEPAM dosage: unknown. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Male patient, 81 years of age, weighting 159.0 lb, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: disorientation, oxygen saturation decreased, respiratory depression. LORAZEPAM dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LORAZEPAM problem on Aug 06, 2006. Male patient, 78 years of age, weighting 240.3 lb, was diagnosed with agitation, restlessness and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dehydration, depressed level of consciousness, mental status changes, renal failure acute, respiratory rate increased, urosepsis. LORAZEPAM dosage: 2 MG ONCE IV BOLUS. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Physician from GERMANY on July 24, 2006. Female patient, 31 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: suicide attempt, tachycardia. LORAZEPAM dosage: 14 MG ONCE PO. Patient was hospitalized. Patient recovered.

Physician from ARGENTINA reported LORAZEPAM problem on July 24, 2006. Female patient, 66 years of age, was diagnosed with overdose and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, blood pressure increased, coma, heart rate increased, neuroleptic malignant syndrome, serotonin syndrome. LORAZEPAM dosage: 10 MG ONCE. During the same period patient was treated with TRANYLCYPROMINE SULPHATE, TRIFLUOPERAZINE, FLUOXETINE, REMIFENTANIL, MIDAZOLAM, PANCURONIUM BROMIDE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Physician from ARGENTINA on Aug 10, 2006. Female patient, 66 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: eye movement disorder, serotonin syndrome. LORAZEPAM dosage: 10 MG, SINGLE, ORAL. During the same period patient was treated with FLUOXETINE, TRANYLCYPROMINE SULPHATE, TRIFLUOPERAZINE, REMIFENTANIL. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRIA reported LORAZEPAM problem on Aug 18, 2006. Male patient, 61 years of age, was treated with LORAZEPAM. LORAZEPAM dosage: unknown. During the same period patient was treated with PANTOZOL, ALENDRONATE, CARBAMAZEPINE, DOXAZOSIN, MIANSERIN, MILNACIPRAN, QUETIAPINE FUMARATE, TRAMADOL. Patient died.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Male patient, 65 years of age, was diagnosed with depression, high density lipoprotein decreased, hypercholesterolaemia, diabetes mellitus, tachyarrhythmia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood glucose increased, glycosylated haemoglobin increased, high density lipoprotein decreased, loss of consciousness, myocardial infarction, respiratory arrest. LORAZEPAM dosage: 2 MG Q DAY PO. During the same period patient was treated with NIASPAN, EFFEXOR, ACTOS, GLUCOPHAGE, GLUCOTROL, LANOXIN, LANTUS. Patient died on 07/11/2006.

Consumer or non-health professional from UNITED KINGDOM reported LORAZEPAM problem on Aug 16, 2006. Male patient, 57 years of age, was diagnosed with schizophrenia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, heart rate irregular, somnolence, tachycardia, ventricular extrasystoles. LORAZEPAM dosage: 1 MG, PRN, ORAL. During the same period patient was treated with CLOZAPINE, VALPROIC ACID. Patient recovered.

LORAZEPAM problem was reported by a Health Professional from SWITZERLAND on Aug 23, 2006. Female patient, 30 years of age, was diagnosed with anxiety, depression and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LORAZEPAM dosage: 2.5 MG Q DAY SL. During the same period patient was treated with XANAX. Patient recovered.

Pharmacist from UNITED STATES reported LORAZEPAM problem on Sept 21, 2006. Male patient, weighting 157.4 lb, was diagnosed with sedation and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, hypotension, loss of consciousness, mydriasis, pupil fixed. LORAZEPAM dosage: 1 MG IV. During the same period patient was treated with CEFAZOLIN, CHLORAL HYDRATE, DEPHENHYDRAMINE, LANSOPRAZOLE. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from FRANCE on Sept 07, 2006. Male patient, 84 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: haematuria, international normalised ratio increased, thrombosis, urinary retention. LORAZEPAM dosage: 1 MG QD PO. During the same period patient was treated with PREVISCAN, EUPANTOL, DIGOXIN, GLUCOR, NOVONORM, NORSET. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported LORAZEPAM problem on Sept 19, 2006. Female patient, 54 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, underweight, weight decreased. LORAZEPAM dosage: unknown. During the same period patient was treated with HALCION, PREMARIN. Patient recovered.

LORAZEPAM problem was reported by a Physician from GERMANY on Sept 15, 2006. Female patient, 33 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: somnolence, tachycardia. LORAZEPAM dosage: 40 MG ONCE PO. During the same period patient was treated with PROMETHAZINE. Patient was hospitalized. Patient recovered.

Health Professional from SWITZERLAND reported LORAZEPAM problem on Sept 19, 2006. Female patient, 52 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, weight decreased. LORAZEPAM dosage: unknown. During the same period patient was treated with HALCION, PREMARIN. Patient recovered.

LORAZEPAM problem was reported by a Pharmacist from UNITED STATES on Oct 04, 2006. Male patient, 55 years of age, weighting 93.04 lb, was diagnosed with restlessness, alcohol withdrawal syndrome and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, alcohol withdrawal syndrome, computerised tomogram abnormal, confusional state, depressed level of consciousness, disorientation, hallucination, increased viscosity of bronchial secretion. LORAZEPAM dosage: 2MG BID PO. During the same period patient was treated with CHLORDIAZEPOXIDE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LORAZEPAM problem on Sept 18, 2006. Female patient, 83 years of age, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: contusion, coordination abnormal, dizziness, fall, gait disturbance. LORAZEPAM dosage: unknown. During the same period patient was treated with AZITHROMYCIN, LEVOFLOXACIN, VANCOMYCIN, BACITRACIN, CEFEPIME, GATIFLOXACIN. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Health Professional from AMERICAN SAMOA on Sept 19, 2006. Female patient, 52 years of age, weighting 102.5 lb, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, weight decreased. LORAZEPAM dosage: unknown. During the same period patient was treated with HALCION, PREMARIN. Patient recovered.

Consumer or non-health professional from AUSTRIA reported LORAZEPAM problem on Oct 20, 2005. Male patient, 32 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: atrioventricular block third degree, convulsion, fall, skin laceration. LORAZEPAM dosage: 6 MG. During the same period patient was treated with HALDOL, COMBIVENT. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 26, 2006. Male patient, 42 years of age, was diagnosed with psychotic disorder and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dyspnoea, muscle rigidity, oxygen saturation decreased, rash, tachycardia. LORAZEPAM dosage: 1MG, UNK; ORAL. During the same period patient was treated with OLANZAPINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORAZEPAM problem on Sept 26, 2006. Male patient, 65 years of age, was diagnosed with depression, high density lipoprotein decreased, hypercholesterolaemia, diabetes mellitus, tachyarrhythmia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cardio-respiratory arrest, haemoglobin decreased, high density lipoprotein decreased, myocardial infarction, scan abdomen abnormal. LORAZEPAM dosage: 2 MG Q DAY PO. During the same period patient was treated with NIASPAN, EFFEXOR, ACTOS, GLUCOPHAGE, GLUCOTROL, LANOXIN, LANTUS. Patient died on 06/11/2006.

LORAZEPAM problem was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, child 3 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: accidental overdose. LORAZEPAM dosage: 7 MG ONCE PO. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported LORAZEPAM problem on Sept 29, 2006. Female patient, 37 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: areflexia, respiratory failure, somnolence, suicide attempt. LORAZEPAM dosage: unknown. During the same period patient was treated with ATOSIL, FLUOXETINE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2005. Male patient, weighting 7.01 lb, was diagnosed with schizophrenia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: talipes. LORAZEPAM dosage: 0.5 MG; EVERY DAY, TRPL. During the same period patient was treated with HALDOL, CANNABIS, COCAINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORAZEPAM problem on Oct 28, 2005. Female patient, 26 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, tachycardia. LORAZEPAM dosage: 7 MG; PO. During the same period patient was treated with CISORDINOL, ZYPREXA, DEPAKENE, HALDOL, TRUXAL, PROTHIPENDYL HYDROCHLORIDE. Patient recovered.

LORAZEPAM problem was reported by a Physician from SWITZERLAND on Oct 06, 2006. Female patient, 89 years of age, was diagnosed with restlessness, depression, fungal infection and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, conjunctivitis, creatinine renal clearance decreased, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, oral intake reduced, stevens-johnson syndrome. LORAZEPAM dosage: 1 MG Q DAY PO. During the same period patient was treated with EFFEXOR, HALDOL, MYCOSTATIN, SEROQUEL, TEMGESIC, NORVASC. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRIA reported LORAZEPAM problem on Oct 09, 2006. Male patient, 56 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. LORAZEPAM dosage: 25 MG QD PO. During the same period patient was treated with CATAPRES, AUGMENTIN, NEXIUM, DOMINAL, HALDOL, TRILEPTAL, OMNIFLORA, CEVITOL. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Health Professional from AUSTRIA on Oct 09, 2006. Female patient, 54 years of age, was diagnosed with schizophrenia, paranoid type and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: delirium, infection, white blood cell count increased. LORAZEPAM dosage: 2.5 MG Q DAY. During the same period patient was treated with CLOZAPINE, FLUPENTIXOL, AKINETON, FLUANXOL, PROPRANOLOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRIA reported LORAZEPAM problem on Oct 09, 2006. Male patient, 52 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diabetes mellitus, hyponatraemia. LORAZEPAM dosage: 3 MG Q DAY. During the same period patient was treated with TRITACE, SIMVASTATIN, METFORMIN, DOMINAL. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2006. Female patient, 79 years of age, weighting 194.0 lb, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: anaemia folate deficiency, anaemia vitamin b12 deficiency, anuria, blood creatinine increased, blood folate decreased, blood thyroid stimulating hormone decreased, blood urea increased, bone operation, dehydration. LORAZEPAM dosage: unknown. During the same period patient was treated with ACETAMINOPHEN W, ZOLOFT, XANAX, LOVENOX, COZAAR, HYPERIUM, LASIX, ESIDRIX. Patient recovered.

Consumer or non-health professional from CANADA reported LORAZEPAM problem on July 30, 2003. Male patient, 48 years of age, was diagnosed with schizophrenia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus insulin-dependent, electrocardiogram qt corrected interval prolonged, hepatic failure, hepatitis c, polydipsia, polyuria, somnolence. LORAZEPAM dosage: 2 MG, BID. During the same period patient was treated with NPH INSULIN, SERTRALINE, COLACE, LIPITOR, RANITIDINE, CLOZARIL. Patient died on 11/03/2006.

LORAZEPAM problem was reported by a Consumer or non-health professional from FRANCE on Oct 19, 2006. Female patient, 28 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, autoimmune hepatitis, hepatitis c virus, hepatitis e, intentional overdose. LORAZEPAM dosage: 1 MG Q DAY; PO. During the same period patient was treated with DEROXAT, ZOLPIDEM TARTRATE, TRANXENE, GESTODENE AND ETHINYL ESTRADIOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LORAZEPAM problem on Oct 24, 2006. Female patient was diagnosed with insomnia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, fatigue, fear, feeling abnormal, malaise, nightmare, palpitations, restlessness. LORAZEPAM dosage: unknown. During the same period patient was treated with ZOPICLONE, TEMAZEPAM. Patient recovered.

LORAZEPAM problem was reported by a Health Professional from GERMANY on Nov 07, 2006. Female patient, 32 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: fatigue, gastrointestinal motility disorder, intentional overdose, suicide attempt, tachycardia. LORAZEPAM dosage: 20 TABLETS (OVERDOSE AMOUNT 10 MG). During the same period patient was treated with CARBAMAZEPINE, SEROQUEL, VENLAFAXINE, ZYPREXA. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LORAZEPAM problem on Oct 24, 2006. Female patient, 34 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, poisoning, respiratory arrest. LORAZEPAM dosage: unknown. During the same period patient was treated with ACETAMINOPHEN AND OXYCODONE, CARISOPRODOL. Patient died.

LORAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 68 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. LORAZEPAM dosage: unknown. During the same period patient was treated with CLONAZEPAM, GLIPIZIDE. Patient died.

Physician from UNITED STATES reported LORAZEPAM problem on Oct 24, 2006. Female patient, 38 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, poisoning, respiratory arrest. LORAZEPAM dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE. Patient died.

LORAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 31 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, poisoning, respiratory arrest. LORAZEPAM dosage: unknown. During the same period patient was treated with MIRTAZAPINE, ACETAMINOPHEN. Patient died.

Physician from UNITED STATES reported LORAZEPAM problem on Oct 24, 2006. Female patient, 42 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, poisoning, respiratory arrest. LORAZEPAM dosage: unknown. During the same period patient was treated with CLONAZEPAM, VENLAFAXINE. Patient died.

LORAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 38 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: poisoning. LORAZEPAM dosage: unknown. During the same period patient was treated with COCAINE, HALOPERIDOL. Patient died.

Physician from UNITED STATES reported LORAZEPAM problem on Oct 24, 2006. Female patient, 42 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. LORAZEPAM dosage: unknown. During the same period patient was treated with BACLOFEN, CITALOPRAM. Patient died.

LORAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 53 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. LORAZEPAM dosage: unknown. During the same period patient was treated with VERAPAMIL, LISINOPRIL. Patient died.

Physician from UNITED STATES reported LORAZEPAM problem on Oct 24, 2006. Female patient, 36 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. LORAZEPAM dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, QUETIAPINE FUMARATE. Patient died.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Female patient, 80 years of age, was diagnosed with nerve block and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, paralysis flaccid, paraparesis. LORAZEPAM dosage: 1 MG ONCE PO. During the same period patient was treated with CELESTONE SOLUSPAN, LIDOCAINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LORAZEPAM problem on Nov 17, 2006. Female patient was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. LORAZEPAM dosage: 1 MG, INTRAVENOUS. During the same period patient was treated with LIDOCAINE. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 14, 2006. Female patient, 32 years of age, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: confusional state, disorientation, somnolence. LORAZEPAM dosage: unknown. During the same period patient was treated with FLUOXETINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORAZEPAM problem on Sept 18, 2006. Female patient, 78 years of age, was diagnosed with depression, blood pressure and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: aphasia, fear, feeling abnormal, hallucination, memory impairment, visual disturbance. LORAZEPAM dosage: unknown. During the same period patient was treated with CYMBALTA, PRINIVIL, ATENOLOL. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 27, 2006. Female patient, 32 years of age, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, disorientation, overdose, somnolence. LORAZEPAM dosage: 10 MG, ORAL. During the same period patient was treated with FLUOXETINE. Patient recovered.

Pharmacist from UNITED STATES reported LORAZEPAM problem on Dec 06, 2006. Male patient, 62 years of age, weighting 106.0 lb, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness. LORAZEPAM dosage: 0.5MG PO ONCE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from FRANCE on Nov 21, 2006. Male patient, 49 years of age, was diagnosed with depression and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count decreased. LORAZEPAM dosage: unknown. During the same period patient was treated with EFFEXOR, NOOTROPYL, TERCIAN. Patient was hospitalized. Patient recovered.

Health Professional from CANADA reported LORAZEPAM problem on July 30, 2003. Male patient, 49 years of age, weighting 297.6 lb, was diagnosed with schizophrenia and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: disease progression, electrocardiogram qt corrected interval prolonged, hepatic failure, hepatitis c, liver function test abnormal, polydipsia, polyuria, somnolence. LORAZEPAM dosage: 2 MG, BID. During the same period patient was treated with INSULIN, SERTRALINE, COLACE, LIPITOR, RANITIDINE, CLOZARIL. Patient died on 11/02/2006.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2006. Female patient, 36 years of age, weighting 105.0 lb, was diagnosed with anxiety, sleep disorder and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, depersonalisation, depression, derealisation, emotional disorder, headache, hearing impaired. LORAZEPAM dosage: .25 MG TWICE DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORAZEPAM problem on Sept 18, 2006. Female patient, 78 years of age, was diagnosed with depression, blood pressure and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: aphasia, balance disorder, disturbance in attention, dizziness, fear, feeling abnormal, gait disturbance, hallucination. LORAZEPAM dosage: unknown. During the same period patient was treated with CYMBALTA, PRINIVIL, ATENOLOL. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Female patient, 31 years of age, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: alcohol use, amnesia, anxiety, contusion, loss of consciousness, nausea, tachycardia, vomiting. LORAZEPAM dosage: unknown. During the same period patient was treated with PAROXETINE, TRAZODONE, ALCOHOL. Patient recovered.

Consumer or non-health professional from reported LORAZEPAM problem on July 04, 2007. Female patient, 63 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. LORAZEPAM dosage: unknown. During the same period patient was treated with TIROXIN, OMEPRAZOLE, IAPRAZINE, CLOTIAPINE, VALPROIC ACID, CLONAZEPAM, PIPERACILLIN. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Consumer or non-health professional from JAPAN on June 21, 2007. Female patient, 39 years of age, was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: areflexia, aspiration, blood pressure decreased, dialysis, loss of consciousness, metabolic acidosis, neuroleptic malignant syndrome. LORAZEPAM dosage: unknown. During the same period patient was treated with AMOXAPINE, FLUNITRAZEPAM, ETIZOLAM. Patient was hospitalized. Patient died.

Pharmacist from UNITED STATES reported LORAZEPAM problem on July 23, 2007. Male patient, 37 years of age, weighting 208.6 lb, was diagnosed with agitation, pain and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pain, syncope, unresponsive to stimuli. LORAZEPAM dosage: 1 MG ONCE IV. During the same period patient was treated with MORPHINE. Patient was hospitalized. Patient recovered.

LORAZEPAM problem was reported by a Pharmacist from UNITED STATES on July 25, 2007. Male patient, weighting 196.0 lb, was diagnosed with agitation, thinking abnormal and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, somnolence, stupor. LORAZEPAM dosage: 1MG ONCE PO. During the same period patient was treated with QUETIAPINE FUMARATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported LORAZEPAM problem on July 10, 2007. Male patient, 42 years of age, was diagnosed with anxiety and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: accommodation disorder, disturbance in attention, fatigue, motor dysfunction. LORAZEPAM dosage: (0.25 MG QD ORAL), (0.5 MG QD ORAL). During the same period patient was treated with FLUSPIRILENE, VALERIAN. Patient recovered.

LORAZEPAM problem was reported by a Health Professional from GERMANY on July 16, 2007. Female patient was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: gastrointestinal sounds abnormal, hypotension, somnolence, suicide attempt. LORAZEPAM dosage: (16.5 MG 1X, ORAL). During the same period patient was treated with ADUMBRAN, CHLORPROTHIXENE, SEROQUEL, ZOPICLONE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LORAZEPAM problem on Aug 03, 2007. Male patient, 56 years of age, was diagnosed with convulsion, prophylaxis against alcoholic withdrawal syndrome and was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, condition aggravated. LORAZEPAM dosage: 2MG QID IV. Patient was hospitalized. Patient recovered.

Showing 1-75 of 184 Next >

Ask Our Patient Community about LORAZEPAM
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib)